non-Hodgkin lymphoma
Kite Pharma climbs on strong data showing in lymphoma trial
March 1, 2017Research and Development kite pharma, non-Hodgkin lymphoma
Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
Phase II failure sees stock plunge and job cutbacks for Infinity Pharmaceuticals
June 15, 2016Research and Development, Sales and Marketing AbbVie, infinity pharmaceuticals, non-Hodgkin lymphoma, trial failure
Shares at Infinity Pharmaceuticals (NASDAQ: INFI) fell around 70% upon the announcement of new Phase II data for their non-Hodgkin …
Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma
March 18, 2016Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma
Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …
Spectrum wins FDA approval for rare cancer drug
July 4, 2014Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma
In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …
